Ozempic and other semaglutide medications for weight loss have been linked to hair loss on social media. Experts share who is ...

Ms Hogan, from Edinburgh, says she agrees with Health Secretary Wes Streeting that the drug could potentially help people ...

As Wes Streeting suggests new weight-loss jabs could be given to unemployed people to help them get back into work, doctors ...

From wondering what to eat for dinner to "how many calories is this bag of Takis?" But food noise becomes problematic if it’s ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give ...

Semaglutide, the same compound that’s in Ozempic, is part of a class of medications known as glucagon-like peptide 1 (GLP-1) ...

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

WeightWatchers (WW International) (NASDAQ:WW) stock is trading higher on Wednesday, with a session volume strong at 31.45 ...

Novo Nordisk’s stock declined 12% in the past month. Wegovy's sales growth stays under pressure. Read why I'm neutral on NVO ...

As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies, but Bernstein believes that some companies are likely to fare better than ...